Ultragenyx (RARE) outlook: 2026 revenue guidance, cost controls, and key FDA/PDUFA catalysts (DTX401, UX111, GTX-102).
Adawi, Yazan Kur, Mohammad Deeb Bazat The documents, photos, and videos that emerged from Syria during the years of […] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results